Radioactive drug indicated for positron emission tomography (pet) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis
Ended Awarded Last action
- Contract number
- 36C26125N0101
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $869,773
Award facts
- Contract value 100% obligated
- $869,773.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $126,377 | |
| Original award | $743,396 |
About this award
This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is for the delivery of PYLARIFY, a radioactive drug indicated for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis. The contract has a ceiling value of $869,773.32 and a period of performance through September 30, 2025. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. This contract is not set aside for any particular business type.
Quick answers
Who was awarded contract 36C26125N0101?
36C26125N0101 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26125N0101 worth?
The government has obligated $869,773 on 36C26125N0101.
Is contract 36C26125N0101 an order under another contract?
Yes. 36C26125N0101 is a BPA call under 36F79719D0170-36C26123A0025, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0101 competed?
The extent of competition for 36C26125N0101 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award